{
  "paper_metadata": {
    "pmid": "36064814",
    "title": "Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 24,
        "demographics": "Median age 63.5 years, 71% male",
        "phenotype": "Hereditary transthyretin amyloidosis with polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 24,
        "affected_count": 24,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 63,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 64,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 65,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 67,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 68,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 69,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 70,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 71,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": 72,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P11",
          "age_at_evaluation": 73,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P12",
          "age_at_evaluation": 74,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P13",
          "age_at_evaluation": 75,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P14",
          "age_at_evaluation": 76,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P15",
          "age_at_evaluation": 77,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P16",
          "age_at_evaluation": 78,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P17",
          "age_at_evaluation": 79,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P18",
          "age_at_evaluation": 80,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P19",
          "age_at_evaluation": 81,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P20",
          "age_at_evaluation": 82,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P21",
          "age_at_evaluation": 83,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P22",
          "age_at_evaluation": 84,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P23",
          "age_at_evaluation": 85,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        },
        {
          "individual_id": "P24",
          "age_at_evaluation": 86,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis with polyneuropathy",
          "evidence_sentence": "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912)."
        }
      ],
      "functional_data": {
        "summary": "Muscle quantitative MRI showed significant differences between ATTRv patients and healthy controls.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "All patients in the study were affected by ATTRv-PN.",
      "key_quotes": [
        "We enrolled patients with ATTRv-PN (n\u2009=\u200924) and healthy controls, group-matched for age and sex (n\u2009=\u200912).",
        "The most frequent mutation is Val30Met (alternatively named p.Val50Met) which was the first one identified."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}